These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18359773)

  • 1. Major histocompatibility class II transactivator expression in smooth muscle cells from A2b adenosine receptor knock-out mice: cross-talk between the adenosine and interferon-gamma signaling.
    Xu Y; Ravid K; Smith BD
    J Biol Chem; 2008 May; 283(21):14213-20. PubMed ID: 18359773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells.
    Fang M; Xia J; Wu X; Kong H; Wang H; Xie W; Xu Y
    Eur J Immunol; 2013 Aug; 43(8):2162-73. PubMed ID: 23681904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
    Butticè G; Miller J; Wang L; Smith BD
    Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma down-regulates adenosine 2b receptor-mediated signaling and short circuit current in the intestinal epithelia by inhibiting the expression of adenylate cyclase.
    Kolachala V; Asamoah V; Wang L; Srinivasan S; Merlin D; Sitaraman SV
    J Biol Chem; 2005 Feb; 280(6):4048-57. PubMed ID: 15550390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X; Fang M; Li P; Fang F; Xu Y
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A2b adenosine signaling represses CIITA transcription via an epigenetic mechanism in vascular smooth muscle cells.
    Xia J; Fang M; Wu X; Yang Y; Yu L; Xu H; Kong H; Tan Q; Wang H; Xie W; Xu Y
    Biochim Biophys Acta; 2015 Jun; 1849(6):665-76. PubMed ID: 25765819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
    J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression.
    Xu Y; Farmer SR; Smith BD
    J Biol Chem; 2007 Sep; 282(36):26046-56. PubMed ID: 17611194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis.
    Xu Y; Luchsinger L; Lucey EC; Smith BD
    Am J Respir Cell Mol Biol; 2011 Jun; 44(6):898-905. PubMed ID: 20705943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells.
    Pazmany T; Tomasi TB
    J Neuroimmunol; 2006 Mar; 172(1-2):18-26. PubMed ID: 16360884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA.
    Londhe P; Davie JK
    Mol Cell Biol; 2011 Jul; 31(14):2854-66. PubMed ID: 21576360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
    Xu Y; Wang L; Butticè G; Sengupta PK; Smith BD
    J Biol Chem; 2004 Oct; 279(40):41319-32. PubMed ID: 15247294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression.
    Dong Y; Tang L; Letterio JJ; Benveniste EN
    J Immunol; 2001 Jul; 167(1):311-9. PubMed ID: 11418665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
    Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
    J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
    Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.